20020595

Ended Purchase Order Awarded

Contract number
N6311620P0594
Awardee
Awarding agency
Obligated
$80,858

Award facts

Opportunity
Contract value 100% obligated
$80,858.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an existing Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with BUMED. The purchase order does not have a set-aside designation. The items procured will be used in laboratories at the Naval Health Research Center in San Diego, California.

Quick answers

Who was awarded contract N6311620P0594?

N6311620P0594 was awarded to Illumina, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 29, 2020.

How much is contract N6311620P0594 worth?

The government has obligated $80,858 on N6311620P0594.

Was contract N6311620P0594 competed?

The extent of competition for N6311620P0594 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award